Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet Infectious …, 2015 - thelancet.com
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena, M Espinoza… - 2015 - cabidigitallibrary.org
Background: Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

[PDF][PDF] Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open …

M O'Ryan, AS Bandyopadhyay, R Villena, M Espinoza… - 2015 - repositorio.udd.cl
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV
(tOPV) globally by April, 2016, preceded by the introduction of at least one dose of …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet. Infectious …, 2015 - europepmc.org
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena, M Espinoza… - 2015 - pubmed.ncbi.nlm.nih.gov
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet Infectious …, 2015 - infona.pl
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV
(tOPV) globally by April, 2016, preceded by the introduction of at least one dose of …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan Gallardo, AS Bandyopadhyay… - 2015 - repositorio.uchile.cl
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet Infectious …, 2015 - Elsevier
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …

M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet Infectious …, 2015 - hero.epa.gov
BACKGROUND: Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to
replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least …